- Home
- ISPO vs APLT Comparison
ISPO vs APLT Comparison
Compare ISPO & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPO
- APLT
- Stock Information
- Founded
- ISPO 2010
- APLT 2016
- Country
- ISPO United States
- APLT United States
- Employees
- ISPO N/A
- APLT N/A
- Industry
- ISPO Blank Checks
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- ISPO Finance
- APLT Health Care
- Exchange
- ISPO Nasdaq
- APLT Nasdaq
- Market Cap
- ISPO 44.3M
- APLT 44.0M
- IPO Year
- ISPO N/A
- APLT 2019
- Fundamental
- Price
- ISPO $3.05
- APLT $0.46
- Analyst Decision
- ISPO
- APLT Buy
- Analyst Count
- ISPO 0
- APLT 7
- Target Price
- ISPO N/A
- APLT $6.10
- AVG Volume (30 Days)
- ISPO 48.5K
- APLT 2.7M
- Earning Date
- ISPO 08-12-2025
- APLT 08-06-2025
- Dividend Yield
- ISPO N/A
- APLT N/A
- EPS Growth
- ISPO N/A
- APLT N/A
- EPS
- ISPO N/A
- APLT N/A
- Revenue
- ISPO $265,499,000.00
- APLT $265,000.00
- Revenue This Year
- ISPO N/A
- APLT $415.60
- Revenue Next Year
- ISPO $148.67
- APLT $1,323.96
- P/E Ratio
- ISPO N/A
- APLT N/A
- Revenue Growth
- ISPO N/A
- APLT N/A
- 52 Week Low
- ISPO $3.01
- APLT $0.30
- 52 Week High
- ISPO $9.31
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- ISPO 35.87
- APLT 65.27
- Support Level
- ISPO $3.16
- APLT $0.34
- Resistance Level
- ISPO $3.41
- APLT $0.36
- Average True Range (ATR)
- ISPO 0.24
- APLT 0.04
- MACD
- ISPO -0.06
- APLT 0.01
- Stochastic Oscillator
- ISPO 5.63
- APLT 91.01
About ISPO Inspirato Incorporated
Inspirato Inc is a private, luxury hospitality club that provides its members with access to an exclusive portfolio of high-end vacation homes, luxury hotels, and curated travel experiences worldwide. The club offers personalized service, dedicated trip planning, and seamless access to exceptional properties through its innovative model designed to ensure the service, certainty and value that discerning customers demand. The Inspirato portfolio of curated luxury vacation options includes approximately 350 private luxury vacation homes and accommodations at over 220 luxury hotel and resort partners in over 180 destinations around the world.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.